浙江天册律师事务所 关于 宏润建设集团股份有限公司 2025 年第二次临时股东大会的 法律意见书 浙江省杭州市杭大路 1 号黄龙世纪广场 A 座 11 楼邮编 310007 电话：0571 8790 111 传真：0571 8790 1500 https://www.tclawfirm.com/ 法律意见书 浙江天册律师事务所 关于宏润建设集团股份有限公司 2025 年第二次临时股东大会 的法律意见书 编号：TCYJS2025H2218 号 致：宏润建设集团股份有限公司 浙江天册律师事务所（以下简称"本所"）接受宏润建设集团股份有限公司 （以下简称"宏润建设"或"公司"）的委托，指派本所律师参加公司 2025 年 第二次临时股东大会（以下简称"本次股东大会"），并根据《中华人民共和国 证券法》（以下简称"《证券法》"）、《中华人民共和国公司法》（以下简称 "《公司法》"）和《上市公司股东会规则》（以下简称"《股东会规则》"） 等中华人民共和国现行有效的法律、行政法规、规章和其他规范性文件以及现行 有效的《宏润建设集团股份有限公司章程》（以下简称"《公司章程》"）的相 关规定，出具本法律意见书。 法律意见书 （ ...

Group 1 - The company Hongrun Construction has recently received over ten national and provincial awards in the fields of technological innovation and quality excellence for its Ningbo project, demonstrating its technical prowess and project management capabilities recognized by industry authorities [1] - The company has conducted four research projects based on the Ningbo key project, published three professional papers (including one SCI paper), applied for 26 patents (including six invention patents), and obtained 23 authorized patents (including four invention patents) [1] - Hongrun Construction has been awarded four national QC achievement awards and two national BIM application skill competition achievement awards, with its Ningbo rail transit TJ7015 project team winning a prestigious title for quality management [1] Group 2 - Hongrun Construction is one of the few domestic private enterprises with dual special-grade qualifications in municipal public and construction engineering contracting, as well as first-class qualifications in various other construction fields [2] - The company has a stable management team that emphasizes technological innovation, R&D investment, and talent development, having accumulated core technologies in urban rail transit, bridges, and tunnels [2] - The recent accolades affirm the company's commitment to its operational philosophy of technological innovation and quality excellence, with plans to focus on key technologies and accelerate the application of research outcomes [2]

登录新浪财经APP 搜索【信披】查看更多考评等级 二、股东所持股份累计被质押的情况 证券代码：002062 证券简称：宏润建设 公告编号：2025-069 截至公告披露日，上述股东及其一致行动人所持质押股份情况如下： 宏润建设集团股份有限公司 关于股东所持公司部分股份解除质押的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 宏润建设集团股份有限公司（以下简称"公司"）近日接到公司控股股东浙江宏润控股有限公司（以下简 称"宏润控股"）函告，获悉上述股东所持公司部分股份解除质押，具体事项如下： 一、股东所持股份解除质押的基本情况 ■ ■ 三、备查文件 1、解除证券质押登记凭证； 2、中国证券登记结算有限责任公司股份冻结明细。 特此公告。 宏润建设集团股份有限公司董事会 2025年12月10日 ...

（文章来源：证券日报） 证券日报网讯 12月9日晚间，宏润建设发布公告称，公司近日接到公司控股股东浙江宏润控股有限公司 函告，获悉上述股东所持公司部分股份解除质押，本次解除质押股数为3830万股。 ...

Group 1 - The company, Hongrun Construction, announced the release of 38.3 million shares from pledge by its controlling shareholder, Zhejiang Hongrun Holdings [1] - As of the announcement date, the total pledged shares by Hongrun Holdings amount to approximately 198 million shares, representing 52.6% of its holdings [1] - The company’s market capitalization is reported to be 11.9 billion yuan [1] Group 2 - For the first half of 2025, the revenue composition of Hongrun Construction is as follows: 37.56% from rail transit projects, 25.88% from municipal projects, 20.8% from new energy business, 10.28% from construction projects, and 4.86% from real estate sales [1] - The total pledged shares by Zheng Hongfang amount to 9 million shares, which is 6.57% of his holdings [1]

南财智讯12月9日电，宏润建设公告，公司近日接到控股股东浙江宏润控股有限公司函告，获悉其持有 的公司3830.00万股股份已解除质押，本次解除质押股份占其所持股份比例的10.15%，占公司总股本的 3.10%。 ...

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 宏润建设集团股份有限公司（以下简称"公司"）近日接到公司控股股东浙江 宏润控股有限公司（以下简称"宏润控股"）函告，获悉上述股东所持公司部分 股份解除质押，具体事项如下： 证券代码：002062 证券简称：宏润建设 公告编号：2025-069 宏润建设集团股份有限公司 关于股东所持公司部分股份解除质押的公告 三、备查文件 1、解除证券质押登记凭证； 2、中国证券登记结算有限责任公司股份冻结明细。 特此公告。 宏润建设集团股份有限公司董事会 2025 年 12 月 10 日 | 股东 | 是否为控股股东或 | 本次解除 | 占其所持 | 占公司总 | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 名称 | 第一大股东及其一 | 质押股数 | 股份比 | 股本比 | 起始日 | 解除日期 | 质权人 | | | 致行动人 | （万股） | 例% | 例% | | | | | 宏润 | 是 | | | | 2022 年 | 2025 年 | 中国民生 ...

Core Points - The Shanghai Composite Index is at 3917.00 points, slightly down by 0.18%, and remains above the five-day moving average [1] - The total trading volume of A-shares today is 951.257 billion yuan, with 394 A-shares breaking through the five-day moving average [1] Summary by Category Stock Performance - Notable stocks with significant deviation from the five-day moving average include: - Hengxin Dongfang (300081) with a deviation rate of 16.27% and a daily increase of 20.04% [1] - Dapeng Industrial (920091) with a deviation rate of 11.52% and a daily increase of 14.45% [1] - Maoye Commercial (600828) with a deviation rate of 7.82% and a daily increase of 10.02% [1] Trading Metrics - The trading turnover rates for the top stocks are as follows: - Hengxin Dongfang at 21.04% [1] - Dapeng Industrial at 39.04% [1] - Maoye Commercial at 6.05% [1] Additional Stocks - Other stocks with notable performance include: - Hehua Co., Ltd. (000953) with a daily increase of 9.96% and a deviation rate of 7.52% [1] - Qixin Group (002301) with a daily increase of 10.00% and a deviation rate of 6.98% [1] - Star Technology (300256) with a daily increase of 8.20% and a deviation rate of 6.50% [1]

Group 1 - Weidi Co., Ltd. plans to acquire control of Jiuxing Precision Technology, which is expected to constitute a major asset restructuring. The company will pay cash to acquire 51% of the equity from Jiangsu Zhiyue Tiancheng Enterprise Management Co., Ltd. and Jiuxing Precision Technology, aiming to gain at least 51% voting rights [2] - Purun Co., Ltd. intends to purchase 49% equity of high-performance storage company Noah Changtian through issuing shares, convertible bonds, and cash payments. Upon completion, Purun will hold 100% of Noah Changtian, which specializes in high-performance 2D NAND and derivative storage products [3] - ST Yishite is undergoing a significant share transfer, with Jiangjiang Industrial Group acquiring 4.34 billion shares, representing 18.66% of the total share capital, at a price of 5.61 yuan per share, totaling 2.437 billion yuan [5] Group 2 - Midea Group has completed its share repurchase plan, buying back 135 million shares, accounting for 1.76% of the total share capital, with a total expenditure of approximately 10 billion yuan [6] - Jingji Agricultural plans to repurchase shares using self-raised funds, with a total amount between 100 million and 200 million yuan, at a maximum price of 23.7 yuan per share [6] - Helen Zhe intends to repurchase shares with a total amount between 50 million and 100 million yuan, at a maximum price of 7.5 yuan per share [7] Group 3 - Shengda Resources plans to acquire 60% equity of Yichun Jinshi Mining for 500 million yuan, which will become a subsidiary after the transaction [7] - Guangju Energy is participating in the public transfer of an 8% stake in Shenzhen Mawan Power, aiming to increase its holding from 6.42% to 14.42% [8] - Zhongrong Marine plans to invest 2.58 billion yuan in Guangdong Yantian Port for a 20% stake through its wholly-owned subsidiary [15]

Group 1 - Cambridge Technology plans to invest 400 million yuan to establish a fund focused on optical devices and chips, aiming to invest in early-stage and growth-stage companies in the hard technology sector [1] - Tunnel Corporation's consortium won a bid for a highway project in Henan with a total investment of 6.49 billion yuan, using a BOT model for a 33.25-year cooperation period [2] - Hongrun Construction won a bid for a project worth 230 million yuan, which represents 3.88% of the company's projected revenue for 2024 [3] Group 2 - Tongrentang's product, Canling Baizhu Powder, received product registration approval from Health Canada, aimed at treating symptoms related to spleen and stomach weakness [4] - Hunan Baiyin announced a scheduled annual maintenance from December 9, 2025, to January 5, 2026, for equipment and facilities [5] - Changchun Gaoxin's subsidiary had two drugs included in the national medical insurance catalog for 2025 [6] Group 3 - Dongfang Securities' chairman resigned due to work relocation [7] - Xuantai Pharmaceutical's product, Sitagliptin Metformin Sustained-Release Tablets, was renewed for inclusion in the national medical insurance catalog [8] - ST Weihai was pre-selected for a smart agriculture EPC project with a bid of 652 million yuan, accounting for 26.27% of the company's projected revenue for 2024 [9] Group 4 - Guoxin Technology successfully tested an anti-quantum password financial POS chip, supporting both traditional and quantum-resistant algorithms [10] - Huaren Health's subsidiary received acceptance for a drug registration application for Lactulose Oral Solution, a common laxative [11] - Ankai Bus reported a 57.71% year-on-year increase in sales for the first 11 months of the year [12] Group 5 - Zhongyan Dadi's subsidiary won a bid for a project worth 73.86 million yuan [13] - Zhejiang Rongtai plans to invest 77 million USD in a factory in Thailand, focusing on mica paper and robot components production [14] - Optoelectronics plans to use up to 450 million yuan of idle funds for cash management [15] Group 6 - Tianyu Biological reported a 45.15% year-on-year decline in sales revenue from pig sales in November [16] - Daqin Railway's cargo transport volume increased by 1.75% year-on-year in November [17] - Yabo Co. won a bid for a heavy truck charging station project worth 3.616 million yuan [18] Group 7 - Hongri Pharmaceutical's product continues to be included in the national medical insurance catalog [19] - Jinggong Steel Structure signed a contract for steel structure installation worth approximately 470 million yuan for an overseas project [20] - Xizang Pharmaceutical's product, Xinhuasuan, continues to be included in the national medical insurance catalog [21] Group 8 - Guangdong Electric Power A announced the successful commissioning of a 1000MW unit at the Maoming Boge Power Plant [22] - Fuan Pharmaceutical's product, Palivizumab Injection, was newly included in the national medical insurance catalog [23] - Lizhu Group reported that 194 products were included in the 2025 national medical insurance catalog [24] Group 9 - Haisan Pharmaceutical's injection of Lantanol was included in the national medical insurance catalog [25] - Zhongtong Bus reported a 39.53% year-on-year increase in sales volume in November [26] - Shaanxi Coal Industry reported a 6.03% year-on-year increase in coal production in November [27] Group 10 - Haooubo's subsidiary received a medical device registration certificate for an IgG4 testing kit [28] - Yaopi Glass plans to invest 690 million yuan in new automotive glass production lines [30] - Huadian International completed the issuance of 2 billion yuan in medium-term notes [31] Group 11 - Zhongzai Zihuan's subsidiary won a bid for a green recycling project worth 205 million yuan [32] - Dabeinong reported a 25.26% year-on-year decline in sales revenue from pig sales in November [33] - Xiangjia Co. reported a 3.77% year-on-year increase in live poultry sales revenue in November [34] Group 12 - Huanxu Electronics reported a consolidated revenue of 5.198 billion yuan in November, a decrease of 3.34% year-on-year [35] - Aonong Biological reported a 72.21% year-on-year increase in pig sales volume in November [36] - Samsung Medical's subsidiary was pre-selected for a procurement project worth approximately 108 million yuan [37]